Orviva

Learn · Variants · G6PD

rs5030868 G6PD

Normal G6PD function at Mediterranean variant position.

Imported from public databases · not individually reviewed Drug response · Risk / effect allele: A · dbSNP

What is rs5030868?

rs5030868 is a single-nucleotide polymorphism (SNP) in the G6PD gene (Glucose-6-phosphate dehydrogenase). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as GG. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs5030868 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
GGtypicalNormal G6PD function at Mediterranean variant position.90%
GAincreasedG6PD Mediterranean variant carrier. Severe G6PD deficiency. Rasburicase, primaquine, dapsone contraindicated.90%
AAincreasedG6PD Mediterranean variant homozygous/hemizygous. Severe G6PD deficiency.90%

Is rs5030868 on 23andMe and AncestryDNA chips?

Chip coverage is not recorded for this variant. Orviva reports it when a raw-data file contains it directly or via a well-correlated proxy SNP, and says so when it does not.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.